151. USP35 activated by miR let-7a inhibits cell proliferation and NF-κB activation through stabilization of ABIN-2
- Author
-
Lina Wang, Yani Lin, Weiwen Chen, Chunli Yin, Shihu Zhao, Anli Jiang, Pengju Zhang, and Chunyan Liu
- Subjects
deubiquitylase ,Blotting, Western ,Regulator ,Mice, Nude ,Biology ,Transfection ,TNFAIP3 ,Polymerase Chain Reaction ,NF-κB ,chemistry.chemical_compound ,Mice ,In vivo ,Cell Line, Tumor ,Neoplasms ,Endopeptidases ,medicine ,Animals ,Humans ,Immunoprecipitation ,Adaptor Proteins, Signal Transducing ,Cell Proliferation ,Mice, Inbred BALB C ,Cell growth ,miR let-7a ,NF-kappa B ,Cancer ,USP35 ,medicine.disease ,In vitro ,Cell biology ,Enzyme Activation ,Gene Expression Regulation, Neoplastic ,MicroRNAs ,ABIN-2 ,Oncology ,chemistry ,Heterografts ,Deubiquitination ,Research Paper - Abstract
// Chunyan Liu 1 , Lina Wang 1 , Weiwen Chen 1 , Shihu Zhao 1 , Chunli Yin 1 , Yani Lin 1 , Anli Jiang 1 , Pengju Zhang 1 1 Department of Biochemistry and Molecular Biology, Shandong University School of Medicine, Jinan, Shandong, 250012, P.R. China Correspondence to: Pengju zhang, e-mail: zhpj@sdu.edu.cn Keywords: ABIN-2, deubiquitylase, miR let-7a, NF-κB, USP35 Received: March 09, 2015 Accepted: June 16, 2015 Published: June 26, 2015 ABSTRACT Ubiquitin specific protease 35 (USP35) is a member of deubiquitylases (DUBs). It remains largely unknown about the biological role and the regulation mechanism of USP35. Here, we first identified miR let-7a as a positive regulator of USP35 expression and showed that USP35 expression positively correlates with miR let-7a expression in different cancer cell lines and tissues. Then, we showed that USP35 expression was decreased dramatically in the tumor tissues compared with the adjacent non-cancerous tissues. USP35 overexpression inhibited cell proliferation in vitro and inhibited xenograft tumor growth in vivo . Furthermore, we revealed that USP35 acts as a functional DUB and stabilizes TNFAIP3 interacting protein 2 (ABIN-2) by promoting its deubiquitination. Functionally, both ABIN-2 and USP35 could inhibit TNFα-induced NF-κB activation and overexpression of ABIN-2 alleviated USP35-loss induced activation of NF-κB. Collectively, our data indicated that miR let-7a-regulated USP35 can inhibit NF-κB activation by deubiquitination and stabilization of ABIN-2 protein and eventually inhibit cell proliferation. Overall, our study provides a novel rationale of targeting miR let-7a-USP35-ABIN-2 pathway for the therapy of cancer patients.
- Published
- 2015